Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisha Chen

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Nature Communications|December 5, 2024
Surface reconstruction of wide-bandgap perovskites enables efficient perovskite/silicon tandem solar cellsZheng Fang, Bingru Deng, Yongbin Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2025
Anti-LAG-3 Antibody LBL-007 Plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 TrialDongchen Sun, Gang Chen, Yu Chen, et al.
The American Journal of Gastroenterology|May 27, 2025
Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled TrialPeng Pan, Huixin Chen, Tongchang Wang, et al.
BMC Cancer|July 21, 2023
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapyXiaobin Zheng, Jing Lin, Jiani Xiong, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Signal Transduction and Targeted Therapy|April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 studyShuang Huang, Feng Liu, Song Qu, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Nature Communications|December 5, 2024
Surface reconstruction of wide-bandgap perovskites enables efficient perovskite/silicon tandem solar cellsZheng Fang, Bingru Deng, Yongbin Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2025
Anti-LAG-3 Antibody LBL-007 Plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 TrialDongchen Sun, Gang Chen, Yu Chen, et al.
The American Journal of Gastroenterology|May 27, 2025
Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled TrialPeng Pan, Huixin Chen, Tongchang Wang, et al.
BMC Cancer|July 21, 2023
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapyXiaobin Zheng, Jing Lin, Jiani Xiong, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot studySteven Joel Feigenberg, Francesca Costabile, Ceylan Tanes, et al.
Signal Transduction and Targeted Therapy|April 7, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 studyShuang Huang, Feng Liu, Song Qu, et al.
Pageof 9